57 senators urge CMS to consider feedback before finalizing 340B proposal

AHA News Now

Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services to “carefully consider stakeholder feedback" before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. "The long-term success of the 340B program is... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation

AHA, AAMC express support for 340B program

AHA News Now

The 340B Drug Pricing Program “has enabled hospitals and health systems to support and expand access and services consistent with their mission and the program’s original and ongoing charge,” the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce Committee... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program

Majority of House members urge CMS to abandon proposal to cut 340B program

AHA News Now

Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “Given the important role that the 340B program plays in our... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

HRSA delays to July effective date of 340B drug ceiling price rule

AHA News Now

The Health Resources and Services Administration today delayed to July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. “We are delaying the effective date of the Jan. 5, 2017, final rule to July 1, 2018, because the delay will... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

AHA opposes any further delay of 340B drug ceiling price rule

AHA News Now

The AHA today urged the Health Resources and Services Administration to implement its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers without delay. “Delaying the implementation of the ceiling price and CMPs an additional nine months – from Oct. 1, 2017 to July 1,... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, drug prices

Congress urged to support policies that benefit patients, increase coverage

AHA News Now

Hospital leaders today gathered in Washington, D.C., to urge lawmakers to reject cuts to payments for hospital care and support policies that would benefit patients and increase access to care. During an AHA Advocacy Day briefing, which also was webcast, AHA leaders provided an update on the latest... read more

Topic: Advocacy and Public Policy
Tags: 340B, Coverage, rural, Medicaid, access

AHA to CMS: Withdraw proposed 340B cut

AHA News

The Centers for Medicare & Medicaid Services (CMS) should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA yesterday told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018.

“CMS... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare, regulation, administrative simplification

AHA urges CMS to withdraw proposed cut to 340B program

AHA News Now

The Centers for Medicare & Medicaid Services should withdraw its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program, AHA today told the agency in comments on its outpatient prospective payment system proposed rule for calendar year 2018. “CMS lacks... read more

Topic: Advocacy and Public Policy
Tags: 340B, Medicare, rural, Critical Access Hospitals, regulation, drug prices

CMS advisory panel: Don't finalize proposed 340B cut for 2018

AHA News Now

As urged by the AHA and others, a Centers for Medicare & Medicaid Services advisory panel today recommended that the agency not finalize for 2018 a proposal that would drastically cut Medicare payments for drugs acquired under the 340B Drug Pricing Program. In July, CMS proposed to pay separately-payable,... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA provides update on 340B Office of Pharmacy Affairs Information System

AHA News Now

The Health Resources and Services Administration has provided an update on its new 340B Office of Pharmacy Affairs Information System, which includes a new registration system and a new secure pricing system. HRSA said the registration component of the new 340B OPAIS will be released in mid-September and... read more

Topic: Advocacy and Public Policy
Tag: 340B

Keyword Search

Date